首页> Kardiologiia> Proactive anti-inflammatory therapy in the advanced stages of a new coronavirus infection. Main results of the inpatient phase of the COLORIT study (Colchicin vs. Ruxolitinib and secukinumab in an open, prospective, randomized trial in patients with novel coronavirus infection COVID-19).

Proactive anti-inflammatory therapy in the advanced stages of a new coronavirus infection. Main results of the inpatient phase of the COLORIT study (Colchicin vs. Ruxolitinib and secukinumab in an open, prospective, randomized trial in patients with novel coronavirus infection COVID-19).

导出 LinkOut

翻译打印收藏纠错

第一作者： V Yu,Mareev

第一单位： Medical Research and Educational Center, Lomonosov Moscow State University, Moscow; School of Fundamental Medicine, Lomonosov Moscow State University, Moscow.

作者： V Yu,Mareev ^[1] ; Yа A,Orlova ^[1] ; A G,Plisuk ^[1] ; E P,Pavlikova ^[1] ; Z A,Akopyan ^[1] ; S T,Matskeplishvili ^[2] ; P S,Malahov ^[2] ; T N,Krasnova ^[3] ; E M,Seredenina ^[1] ; A V,Potapenko ^[1] ; М A,Agapov ^[1] ; D A,Asratyan ^[2] ; L I,Dyachuk ^[1] ; L M,Samokhodskaya ^[1] ; E M,Mershina ^[1] ; V E,Sinitsyn ^[1] ; Yu V,Mareev ^[4] ; E A,Shatokhina ^[2] ; Yu L,Begrambekova ^[1] ; A A,Kamalov ^[1]

作者单位： Medical Research and Educational Center, Lomonosov Moscow State University, Moscow; School of Fundamental Medicine, Lomonosov Moscow State University, Moscow. ^[1] Medical Research and Educational Center, Lomonosov Moscow State University, Moscow. ^[2] School of Fundamental Medicine, Lomonosov Moscow State University, Moscow. ^[3] Medical Research and Educational Center, Lomonosov Moscow State University, Moscow; National Medical Research Center of Therapy and Preventive Medicine, Moscow. ^[4]